ETRAVIRINE Side Effects

6965103-6 | Bone Infarction, Cataract, Diabetes Mellitus, Hypertension, Hypothyroidism, Osteoporosis, Pneumonia Cytomegaloviral
on Aug 24, 2010 Female patient from ITALY , 27 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Etravirine (View Usage). Patient experienced the following unwanted or unexpected effects: bone infarction, cataract (What is cataract?), diabetes mellitus, hypertension, hypothyroidism, osteoporosis (What is osteoporosis?), pneumonia cytomegaloviral. Etravirine dosage: . During the same period patient was treated with DARUNAVIR (View Darunavir Review and Darunavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), ENFUVIRTIDE (View Enfuvirtide Review and Enfuvirtide Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ).

6964871-7 | Suicide Attempt
Patient was taking Etravirine (View Usage). Patient had the following side effects: suicide attempt on Aug 25, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 143.3 lb, was diagnosed with hiv infection (What is hiv infection?), bipolar disorder (What is bipolar disorder?) and. Etravirine dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), PROZAC (View Prozac Review and Prozac Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

6922374-X | Skin Exfoliation
Adverse event was reported on Aug 02, 2010 by a Female patient taking Etravirine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 45 years of age, weighting 110.2 lb, After Etravirine was administered, patient had the following side effects: skin exfoliation. During the same period patient was treated with DANURAVIR (View Danuravir Review and Danuravir Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), BENZTROPINE MESYLATE (View Benztropine Mesylate Review and Benztropine Mesylate Label ), EMTRICITABINE (View Emtricitabine Review and Emtricitabine Label ), TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), DOCUSATE (View Docusate Review and Docusate Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ).

6911431-X | Hepatitis C
on Jul 27, 2010 Male patient from GERMANY , weighting 167.6 lb, was diagnosed with hiv infection (What is hiv infection?), type 2 diabetes mellitus and was treated with Etravirine (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis c (What is hepatitis c?). Etravirine dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), ISENTRESS (View Isentress Review and Isentress Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.


6736258-3 | Squamous Cell Carcinoma Of Skin
on May 20, 2010 Male patient from UNITED STATES , 38 years of age, weighting 155.6 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Etravirine (View Usage). Patient had the following side effects: squamous cell carcinoma of skin. Etravirine dosage: 400 Mg Po Q Day. During the same period patient was treated with TRUVADA (200/300 Mg Po Q Day) (View Truvada Review and Truvada Label ).

6660584-X | Cough, Pyrexia, Transaminases Increased, Urticaria Papular
Patient was taking Etravirine (View Usage). After Etravirine was administered, patient had the following side effects: cough, pyrexia, transaminases increased, urticaria papular on Mar 19, 2010 from ITALY Additional patient health information: Female patient , 19 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Etravirine dosage: . During the same period patient was treated with PREZISTA (View Prezista Review and Prezista Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ). Patient was hospitalized.

6534965-9 | Nausea
Adverse event was reported on Jan 11, 2010 by a Male patient taking Etravirine (View Usage) (Dosage: 200 Mg Bid Po) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 51 years of age, Patient experienced the following unwanted or unexpected effects: nausea (What is nausea?).

6518540-8 | Hepatitis C
on Dec 16, 2009 Male patient from GERMANY , weighting 167.6 lb, was diagnosed with hiv infection (What is hiv infection?), type 2 diabetes mellitus and was treated with Etravirine (View Usage). Patient had the following side effects: hepatitis c (What is hepatitis c?). Etravirine dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), ISENTRESS (View Isentress Review and Isentress Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6450785-8 | Urticaria
on Nov 20, 2009 Male patient from UNITED STATES , 69 years of age, weighting 160.0 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Etravirine (View Usage). After Etravirine was administered, patient had the following side effects: urticaria. Etravirine dosage: 200 Mg Bid Po.

6442564-2 | Hepatitis C
Patient was taking Etravirine (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis c (What is hepatitis c?) on Nov 05, 2009 from GERMANY Additional patient health information: Male patient , 42 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Etravirine dosage: . During the same period patient was treated with TDF (View Tdf Review and Tdf Label ), FTC (View Ftc Review and Ftc Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ).

6377171-3 | Fatigue, Lethargy
Adverse event was reported on Sep 24, 2009 by a Male patient taking Etravirine (View Usage) (Dosage: 200mg Bid Po) . Location: UNITED STATES , 60 years of age, Patient had the following side effects: fatigue, lethargy.

6373256-6 | Encephalopathy, Hodgkin's Disease, Liver Disorder
on Sep 18, 2009 Male patient from UNITED KINGDOM , 46 years of age, weighting 176.4 lb, was treated with Etravirine (View Usage). After Etravirine was administered, patient had the following side effects: encephalopathy, hodgkin's disease (What is hodgkin's disease?), liver disorder. Etravirine dosage: . During the same period patient was treated with DARUNAVIR (View Darunavir Review and Darunavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

6347336-5 | Nausea, Neuropathy Peripheral
on Sep 08, 2009 Male patient from UNITED STATES , 50 years of age, weighting 147.7 lb, was diagnosed with urticaria and was treated with Etravirine (View Usage). Patient experienced the following unwanted or unexpected effects: nausea (What is nausea?), neuropathy peripheral. Etravirine dosage: 200mg Bid Po.

6130727-5 | Epistaxis
Patient was taking Etravirine (View Usage). Patient had the following side effects: epistaxis on Mar 13, 2009 from UNITED STATES Additional patient health information: Male patient , 55 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Etravirine dosage: . During the same period patient was treated with DARUNAVIR (View Darunavir Review and Darunavir Label ), MARAVIROC (View Maraviroc Review and Maraviroc Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), IMODIUM (View Imodium Review and Imodium Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

5938983-0 | Epistaxis
Adverse event was reported on Oct 23, 2008 by a Male patient taking Etravirine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 55 years of age, After Etravirine was administered, patient had the following side effects: epistaxis. During the same period patient was treated with DARUNAVIR (View Darunavir Review and Darunavir Label ), MARAVIROC (View Maraviroc Review and Maraviroc Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), IMODIUM (View Imodium Review and Imodium Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

5601195-4 | Blood Creatine Phosphokinase Increased
on Jan 16, 2008 Male patient from FRANCE , weighting 185.2 lb, was diagnosed with hiv infection (What is hiv infection?), gastritis, pain (What is pain?), herpes virus infection and was treated with Etravirine (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased. Etravirine dosage: . During the same period patient was treated with PREZISTA (View Prezista Review and Prezista Label ), NORVIR (View Norvir Review and Norvir Label ), ISENTRESS (View Isentress Review and Isentress Label ), KIVEXA (View Kivexa Review and Kivexa Label ), MOPRAL (View Mopral Review and Mopral Label ), SKENAN (View Skenan Review and Skenan Label ), VALACYCLOVIR (View Valacyclovir Review and Valacyclovir Label ).

5601124-3 | Bronchitis, Dizziness, Herpes Zoster
on Jan 14, 2008 Male patient from GERMANY , weighting 141.1 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Etravirine (View Usage). Patient had the following side effects: bronchitis (What is bronchitis?), dizziness (What is dizziness?), herpes zoster. Etravirine dosage: . During the same period patient was treated with PREZISTA (View Prezista Review and Prezista Label ), CELSENTRI (View Celsentri Review and Celsentri Label ), NORVIR (View Norvir Review and Norvir Label ), KIVEXA (View Kivexa Review and Kivexa Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), PANTOZOL (View Pantozol Review and Pantozol Label ). Patient was hospitalized.

5598015-3 | Adrenal Insufficiency, Hepatitis B, Hypoglycaemia, Nausea
Patient was taking Etravirine (View Usage). After Etravirine was administered, patient had the following side effects: adrenal insufficiency, hepatitis b (What is hepatitis b?), hypoglycaemia, nausea (What is nausea?) on Jan 14, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 167.0 lb, was diagnosed with hiv infection (What is hiv infection?) and. Etravirine dosage: . During the same period patient was treated with PREZISTA (View Prezista Review and Prezista Label ), EFFEXOR XR (Started Pre Trial) (View Effexor Xr Review and Effexor Xr Label ), NORVIR (View Norvir Review and Norvir Label ), MK 0518 (View Mk-0518 Review and Mk-0518 Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), VALTREX (View Valtrex Review and Valtrex Label ). Patient was hospitalized.

5597435-0 | Hyperlipidaemia, Pancreatitis
Adverse event was reported on Jan 09, 2008 by a Male patient taking Etravirine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , weighting 118.0 lb, Patient experienced the following unwanted or unexpected effects: hyperlipidaemia, pancreatitis. During the same period patient was treated with PREZISTA (View Prezista Review and Prezista Label ), NORVIR (View Norvir Review and Norvir Label ), MK 0518 (View Mk-0518 Review and Mk-0518 Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ). Patient was hospitalized.

5597434-9 | Pancreatitis
on Jan 10, 2008 Male patient from UNITED STATES , weighting 238.0 lb, was diagnosed with hiv infection (What is hiv infection?), gastrooesophageal reflux disease, hyperlipidaemia, staphylococcal infection (What is staphylococcal infection?), antifungal prophylaxis and was treated with Etravirine (View Usage). Patient had the following side effects: pancreatitis. Etravirine dosage: Temporary Stop. During the same period patient was treated with TMC114 (View Tmc114 Review and Tmc114 Label ), NORVIR (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ), NEXIUM (Started Pre-trial) (View Nexium Review and Nexium Label ), TRICOR (Started Pre-trial) (View Tricor Review and Tricor Label ), UNASYN (Started Pre-trial) (View Unasyn Review and Unasyn Label ), BACTRIM DS (Started Pre-trial) (View Bactrim Ds Review and Bactrim Ds Label ). Patient was hospitalized.

5591060-3 | Chest Pain, Dyspnoea, Hepatitis
on Jan 07, 2008 Male patient from UNITED STATES , weighting 186.0 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Etravirine (View Usage). After Etravirine was administered, patient had the following side effects: chest pain (What is chest pain?), dyspnoea, hepatitis (What is hepatitis?). Etravirine dosage: Temporary Stop. During the same period patient was treated with PREZISTA (View Prezista Review and Prezista Label ), MK 0518 (View Mk-0518 Review and Mk-0518 Label ), NORVIR (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ). Patient was hospitalized.

5591059-7 | Blood Creatine Phosphokinase Increased
Patient was taking Etravirine (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased on Jan 08, 2008 from FRANCE Additional patient health information: Male patient , weighting 185.2 lb, was diagnosed with hiv infection (What is hiv infection?), pain (What is pain?) and. Etravirine dosage: . During the same period patient was treated with PREZISTA (View Prezista Review and Prezista Label ), NORVIR (View Norvir Review and Norvir Label ), ISENTRESS (View Isentress Review and Isentress Label ), KIVEXA (View Kivexa Review and Kivexa Label ), MOPRAL (View Mopral Review and Mopral Label ), SKENAN (View Skenan Review and Skenan Label ), ZELITREX (View Zelitrex Review and Zelitrex Label ).

5581726-3 | Haemolytic Anaemia, Hepatotoxicity
Adverse event was reported on Dec 27, 2007 by a Male patient taking Etravirine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), antifungal prophylaxis and. Location: UNITED KINGDOM , weighting 154.3 lb, Patient had the following side effects: haemolytic anaemia, hepatotoxicity. During the same period patient was treated with PREZISTA (View Prezista Review and Prezista Label ), MK0518 (View Mk0518 Review and Mk0518 Label ), TRUVADA (View Truvada Review and Truvada Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), SEPTRIN (View Septrin Review and Septrin Label ), 3TC (View 3tc Review and 3tc Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

5579969-8 | Pancreatitis
on Dec 26, 2007 Male patient from UNITED STATES , weighting 238.0 lb, was diagnosed with hiv infection (What is hiv infection?), gastrooesophageal reflux disease, hyperlipidaemia, staphylococcal infection (What is staphylococcal infection?), antifungal prophylaxis and was treated with Etravirine (View Usage). After Etravirine was administered, patient had the following side effects: pancreatitis. Etravirine dosage: Temporary Stop. During the same period patient was treated with TMC114 (View Tmc114 Review and Tmc114 Label ), NORVIR (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ), NEXIUM (Started Pre-trial) (View Nexium Review and Nexium Label ), TRICOR (Started Pre-trial) (View Tricor Review and Tricor Label ), UNASYN (Started Pre-trial) (View Unasyn Review and Unasyn Label ), BACTRIM DS (Started Pre-trial) (View Bactrim Ds Review and Bactrim Ds Label ). Patient was hospitalized.

5578691-1 | Angioedema, Eyelid Oedema, Pyrexia, Rash Erythematous, Rash Morbilliform
on Dec 26, 2007 Female patient from FRANCE , weighting 127.9 lb, was diagnosed with hiv infection (What is hiv infection?), epilepsy (What is epilepsy?) and was treated with Etravirine (View Usage). Patient experienced the following unwanted or unexpected effects: angioedema, eyelid oedema, pyrexia, rash erythematous, rash morbilliform. Etravirine dosage: . During the same period patient was treated with PREZISTA (View Prezista Review and Prezista Label ), FUZEON (View Fuzeon Review and Fuzeon Label ), NORVIR (View Norvir Review and Norvir Label ), DEPAKENE (View Depakene Review and Depakene Label ). Patient was hospitalized.

5576215-6 | Hyperlipidaemia, Pancreatitis
Patient was taking Etravirine (View Usage). Patient had the following side effects: hyperlipidaemia, pancreatitis on Dec 21, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 118.0 lb, was diagnosed with hiv infection (What is hiv infection?) and. Etravirine dosage: . During the same period patient was treated with PREZISTA (View Prezista Review and Prezista Label ), NORVIR (View Norvir Review and Norvir Label ), MK 0518 (View Mk-0518 Review and Mk-0518 Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ). Patient was hospitalized.

5564911-6 | Immune Reconstitution Syndrome
Adverse event was reported on Dec 07, 2007 by a Female patient taking Etravirine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , weighting 123.2 lb, After Etravirine was administered, patient had the following side effects: immune reconstitution syndrome. During the same period patient was treated with PREZISTA (View Prezista Review and Prezista Label ), ISENTRESS (View Isentress Review and Isentress Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), TRUVADA (View Truvada Review and Truvada Label ). Patient was hospitalized.

5564908-6 | Adrenal Insufficiency, Hepatitis B, Hypoglycaemia, Nausea
on Dec 11, 2007 Male patient from UNITED STATES , weighting 167.0 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Etravirine (View Usage). Patient experienced the following unwanted or unexpected effects: adrenal insufficiency, hepatitis b (What is hepatitis b?), hypoglycaemia, nausea (What is nausea?). Etravirine dosage: . During the same period patient was treated with PREZISTA (View Prezista Review and Prezista Label ), NORVIR (View Norvir Review and Norvir Label ), MK 0518 (View Mk-0518 Review and Mk-0518 Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), VALTREX (View Valtrex Review and Valtrex Label ). Patient was hospitalized.

5531430-2 | Blood Creatinine Increased
on Nov 22, 2007 Male patient from UNITED STATES , weighting 147.0 lb, was diagnosed with hiv infection (What is hiv infection?), infection prophylaxis, cardiovascular event prophylaxis and was treated with Etravirine (View Usage). Patient had the following side effects: blood creatinine increased. Etravirine dosage: Permanently Stopped. During the same period patient was treated with TMC114 (View Tmc114 Review and Tmc114 Label ), RITONAVIR (Permanently Stopped) (View Ritonavir Review and Ritonavir Label ), TRUVADA (View Truvada Review and Truvada Label ), ENFUVIRTIDE (View Enfuvirtide Review and Enfuvirtide Label ), VIDEX (View Videx Review and Videx Label ), BACTRIM (View Bactrim Review and Bactrim Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ). Patient was hospitalized.

5525052-7 | Mycobacterium Avium Complex Infection
Patient was taking Etravirine (View Usage). After Etravirine was administered, patient had the following side effects: mycobacterium avium complex infection on Nov 15, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 110.0 lb, was diagnosed with hiv infection (What is hiv infection?) and. Etravirine dosage: . During the same period patient was treated with PREZISTA (View Prezista Review and Prezista Label ), TRUVADA (View Truvada Review and Truvada Label ), ISENTRESS (View Isentress Review and Isentress Label ). Patient was hospitalized.

5523540-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased
Adverse event was reported on Nov 14, 2007 by a Male patient taking Etravirine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), toxoplasmosis prophylaxis and. Location: MEXICO , weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased. During the same period patient was treated with PREZISTA (View Prezista Review and Prezista Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), CLINDAMYCIN HCL (View Clindamycin Hcl Review and Clindamycin Hcl Label ), PYRIMETHAMINE (View Pyrimethamine Review and Pyrimethamine Label ), FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ).

5521794-8 | Hepatitis
on Nov 12, 2007 Male patient from UNITED STATES , weighting 186.0 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Etravirine (View Usage). Patient had the following side effects: hepatitis (What is hepatitis?). Etravirine dosage: Temporary Stop. During the same period patient was treated with PREZISTA (View Prezista Review and Prezista Label ), MK 0518 (View Mk-0518 Review and Mk-0518 Label ), NORVIR (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ). Patient was hospitalized.

5514250-4 | Mycobacterium Avium Complex Infection
on Oct 12, 2007 Male patient from UNITED STATES , weighting 110.0 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Etravirine (View Usage). After Etravirine was administered, patient had the following side effects: mycobacterium avium complex infection. Etravirine dosage: . During the same period patient was treated with PREZISTA (View Prezista Review and Prezista Label ), TRUVADA (View Truvada Review and Truvada Label ), MK 0518 (View Mk-0518 Review and Mk-0518 Label ). Patient was hospitalized.

5478089-0 | Squamous Cell Carcinoma
Patient was taking Etravirine (View Usage). Patient experienced the following unwanted or unexpected effects: squamous cell carcinoma on Oct 01, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 198.4 lb, was diagnosed with hiv infection (What is hiv infection?), hypertension and. Etravirine dosage: . During the same period patient was treated with TMC114 (View Tmc114 Review and Tmc114 Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), RETROVIR (View Retrovir Review and Retrovir Label ), EPIVIR (View Epivir Review and Epivir Label ), FUZEON (View Fuzeon Review and Fuzeon Label ), LOTENSIN (View Lotensin Review and Lotensin Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ).

5455250-2 | Pancytopenia
Adverse event was reported on Sep 07, 2007 by a Female patient taking Etravirine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), prophylaxis and. Location: SWITZERLAND , weighting 112.4 lb, Patient had the following side effects: pancytopenia. During the same period patient was treated with AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), BACTRIM (View Bactrim Review and Bactrim Label ), PREZISTA (View Prezista Review and Prezista Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), FUZEON (View Fuzeon Review and Fuzeon Label ), COTRIMOXAZOLE (View Cotrimoxazole Review and Cotrimoxazole Label ). Patient was hospitalized.

5448336-X | Blood Bilirubin Increased, Jaundice, Pyrexia
on Aug 31, 2007 Male patient from ITALY , weighting 132.3 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Etravirine (View Usage). After Etravirine was administered, patient had the following side effects: blood bilirubin increased, jaundice (What is jaundice?), pyrexia. Etravirine dosage: Permanent Stop. During the same period patient was treated with TMC114 (Permanent Stop) (View Tmc114 Review and Tmc114 Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), RETROVIR (View Retrovir Review and Retrovir Label ), EPIVIR (View Epivir Review and Epivir Label ), VIREAD (View Viread Review and Viread Label ). Patient was hospitalized.

5448334-6 | Blood Creatinine Increased
on Sep 03, 2007 Male patient from UNITED STATES , weighting 147.0 lb, was diagnosed with hiv infection (What is hiv infection?), infection prophylaxis, cardiovascular event prophylaxis and was treated with Etravirine (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased. Etravirine dosage: Permanently Stopped. During the same period patient was treated with TMC114 (View Tmc114 Review and Tmc114 Label ), RITONAVIR (Permanently Stopped) (View Ritonavir Review and Ritonavir Label ), TRUVADA (View Truvada Review and Truvada Label ), ENFUVIRTIDE (View Enfuvirtide Review and Enfuvirtide Label ), VIDEX (View Videx Review and Videx Label ), BACTRIM (View Bactrim Review and Bactrim Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ). Patient was hospitalized.

5447279-5 | Liver Function Test Abnormal
Patient was taking Etravirine (View Usage). Patient had the following side effects: liver function test abnormal on Aug 30, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 207.0 lb, was diagnosed with hiv infection (What is hiv infection?), diarrhoea and. Etravirine dosage: Temporarily Stopped. During the same period patient was treated with PREZISTA (View Prezista Review and Prezista Label ), NORVIR (View Norvir Review and Norvir Label ), HIVID (View Hivid Review and Hivid Label ), FUZEON (View Fuzeon Review and Fuzeon Label ), LOMOTIL (Dosage Reported As 1-2 Every 6 Hours.) (View Lomotil Review and Lomotil Label ), ZOVIRAX (View Zovirax Review and Zovirax Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), MONOPRIL (View Monopril Review and Monopril Label ).

5447224-2 | Coronary Arterial Stent Insertion
Adverse event was reported on Aug 31, 2007 by a Male patient taking Etravirine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), antiviral prophylaxis, dyspepsia and. Location: UNITED STATES , weighting 162.0 lb, After Etravirine was administered, patient had the following side effects: coronary arterial stent insertion. During the same period patient was treated with TMC114 (View Tmc114 Review and Tmc114 Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), FUZEON (View Fuzeon Review and Fuzeon Label ), COMBIVIR (View Combivir Review and Combivir Label ), ACYCLOVIR (Started Pre-trial) (View Acyclovir Review and Acyclovir Label ), LIPRAM (Started Pre-trial) (View Lipram Review and Lipram Label ), DELATESTRYL (Started Pre-trial) (View Delatestryl Review and Delatestryl Label ). Patient was hospitalized.

5447223-0 | Anaemia
on Aug 31, 2007 Female patient from UNITED STATES , weighting 128.0 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Etravirine (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia. Etravirine dosage: . During the same period patient was treated with PREZISTA (View Prezista Review and Prezista Label ), COMBIVIR (View Combivir Review and Combivir Label ), NORVIR (View Norvir Review and Norvir Label ). Patient was hospitalized.

5444485-0 | Immune Reconstitution Syndrome
on Aug 30, 2007 Female patient from UNITED STATES , weighting 123.2 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Etravirine (View Usage). Patient had the following side effects: immune reconstitution syndrome. Etravirine dosage: . During the same period patient was treated with PREZISTA (View Prezista Review and Prezista Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), TRUVADA (View Truvada Review and Truvada Label ). Patient was hospitalized.

5432969-0 | Pancytopenia
Patient was taking Etravirine (View Usage). After Etravirine was administered, patient had the following side effects: pancytopenia on Aug 22, 2007 from SWITZERLAND Additional patient health information: Female patient , weighting 112.4 lb, was diagnosed with hiv infection (What is hiv infection?), prophylaxis and. Etravirine dosage: . During the same period patient was treated with PREZISTA (View Prezista Review and Prezista Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), BACTRIM (View Bactrim Review and Bactrim Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), FUZEON (View Fuzeon Review and Fuzeon Label ), COTRIM (View Cotrim Review and Cotrim Label ). Patient was hospitalized.

5432968-9 | Blood Creatine Phosphokinase Increased
Adverse event was reported on Aug 28, 2007 by a Male patient taking Etravirine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), prophylaxis and. Location: FRANCE , weighting 189.6 lb, Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased. During the same period patient was treated with TMC114 (View Tmc114 Review and Tmc114 Label ), NORVIR (View Norvir Review and Norvir Label ), MK 0518 (View Mk-0518 Review and Mk-0518 Label ), TRIZIVIR (View Trizivir Review and Trizivir Label ), BACTRIM (View Bactrim Review and Bactrim Label ).

5431574-X | Immune Reconstitution Syndrome
on Aug 22, 2007 Female patient from UNITED STATES , weighting 123.2 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Etravirine (View Usage). Patient had the following side effects: immune reconstitution syndrome. Etravirine dosage: . During the same period patient was treated with PREZISTA (View Prezista Review and Prezista Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), TRUVADA (View Truvada Review and Truvada Label ). Patient was hospitalized.

5428930-2 | Anaemia
on Aug 17, 2007 Female patient from UNITED STATES , weighting 128.0 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Etravirine (View Usage). After Etravirine was administered, patient had the following side effects: anaemia. Etravirine dosage: . During the same period patient was treated with PREZISTA (View Prezista Review and Prezista Label ), COMBIVIR (View Combivir Review and Combivir Label ), NORVIR (View Norvir Review and Norvir Label ). Patient was hospitalized.

5427517-5 | Anaemia, Thrombocytopenia
Patient was taking Etravirine (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, thrombocytopenia on Aug 16, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 209.0 lb, was diagnosed with hiv infection (What is hiv infection?), medical diet, herpes simplex (What is herpes simplex?), antifungal prophylaxis and. Etravirine dosage: . During the same period patient was treated with TMC114 (View Tmc114 Review and Tmc114 Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), VIDEX (View Videx Review and Videx Label ), TRUVADA (View Truvada Review and Truvada Label ), VITAMIN AND MINERAL PRENATAL SUPPLEMENT W/ FOLIC ACID CAP (Started Pre-trial) (View Vitamin And Mineral Prenatal Supplement W/ Folic Acid Cap Review and Vitamin And Mineral Prenatal Supplement W/ Folic Acid Cap Label ), ACYCLOVIR (Started Pre-trial) (View Acyclovir Review and Acyclovir Label ), SEPTRA (Started Pre-trial) (View Septra Review and Septra Label ). Patient was hospitalized.

5425886-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Hepatic Steatosis, Hepatitis
Adverse event was reported on Aug 14, 2007 by a Male patient taking Etravirine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), syphilis (What is syphilis?) and. Location: UNITED STATES , weighting 174.0 lb, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, hepatic steatosis, hepatitis (What is hepatitis?). During the same period patient was treated with PREZISTA (View Prezista Review and Prezista Label ), BICILLIN (View Bicillin Review and Bicillin Label ), MK 0518 (View Mk-0518 Review and Mk-0518 Label ), MK 0518 (View Mk-0518 Review and Mk-0518 Label ), TRUVADA (View Truvada Review and Truvada Label ).

5425119-8 | Iridocyclitis
on Aug 14, 2007 Male patient from UNITED STATES , weighting 132.0 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Etravirine (View Usage). After Etravirine was administered, patient had the following side effects: iridocyclitis. Etravirine dosage: . During the same period patient was treated with PREZISTA (View Prezista Review and Prezista Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), TRUVADA (View Truvada Review and Truvada Label ), ENFUVIRTIDE (View Enfuvirtide Review and Enfuvirtide Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), COMBIVENT (View Combivent Review and Combivent Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ).

5423388-1 | Anaemia, Chills, Cough, Immune Reconstitution Syndrome, Pyrexia, Weight Decreased
on Aug 13, 2007 Female patient from UNITED STATES , weighting 123.2 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Etravirine (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, chills, cough, immune reconstitution syndrome, pyrexia, weight decreased. Etravirine dosage: . During the same period patient was treated with PREZISTA (View Prezista Review and Prezista Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), TRUVADA (View Truvada Review and Truvada Label ). Patient was hospitalized.

5420899-X | Cellulitis, Dehydration, Diarrhoea, Kaposi's Sarcoma
Patient was taking Etravirine (View Usage). Patient had the following side effects: cellulitis (What is cellulitis?), dehydration, diarrhoea, kaposi's sarcoma (What is kaposi's sarcoma?) on Aug 10, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 118.0 lb, was diagnosed with hiv infection (What is hiv infection?) and. Etravirine dosage: Temporarily Stopped. During the same period patient was treated with PREZISTA (View Prezista Review and Prezista Label ), NORVIR (View Norvir Review and Norvir Label ), INVESTIGATIONAL INTEGRASE INHIBITORS (View Investigational Integrase Inhibitors Review and Investigational Integrase Inhibitors Label ). Patient was hospitalized.